Tuesday, September 12, 2017

Three more fentanyl analogs to be placed into Schedule I

The DEA announced today a notice of intent to place three more fentanyl analogs into Schedule I of the Controlled Substances Act. These compounds are Methoxyacetylfentanyl, Ortho-Fluorofentanyl, and Tetrahydrofuranfentanyl. 

According to the Federal Register, the first detection of Ortho-Fluorofentanyl in drug seizure evidence was in April 2016 and the first detection of Tetrahydrofuranfentanyl was in March 2017. Methoxyacetylfentanyl was first identified in solid dose evidence in April 2017. There have been multiple confirmed fatalities associated with each of these substances.

These three compounds make a total of nine (9) fentanyl analogs controlled by the DEA since 2015. Others controlled in this time period are Acetylfentanyl (2015), Betahydroxthiofentanyl and Butyrylfentanyl, and Furanylfentanyl (2016), and 4-Fluorisobutyrylfentanyl and Acrylfentanyl(2017).


References

United States DEA (2017) Notice of Intent. Schedules of Controlled Substances: Temporary Placement of Orthofluorofentanyl, Tetrahydrofuranylfentanyl, and Methoxyacetylfentanyl
 into Schedule I. Federal Register. Volume 82, Number 175.
https://www.gpo.gov/fdsys/pkg/FR-2017-09-12/pdf/2017-19283.pdf

No comments:

Post a Comment